Overview
The fund invests globally in a broadly diversified portfolio of actively and passively managed instruments as well as individual investments.
The fund invests in equities, bonds, money market instruments, real estate and other alternative investments and observes the investment regulations contained in the Federal Act on Occupational Retirement, Survivors and Disability Pension Plans (OPA) and the corresponding Occupational Pension Ordinances (OPO2).
Benefits
Flexible use of funds upon retirement.
Investors can benefit globally from diversified market opportunities across asset classes and individual securities as well as across asset managers and investment styles. The investment focus is on Switzerland.
Pursue pension savings goals while at the same time promoting sustainable investing through ESG criteria.
Risks
Features
| Product category |
UBS Privilege Funds
|
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
January 21, 2020
|
| Currency of account |
CHF
|
| Close of financial year |
December 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.71% p.a.
|
| Management fee |
0.55% p.a.
|
| Total expense ratio (TER) |
0.74% p.a.
|
| Minimum investment |
n.a.
|
| Securities no. |
38714605
|
| ISIN |
CH0387146050
|
| Bloomberg Ticker |
CSP35EB SW
|
| Reuters Id |
38714605X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 1.21 | 2.62 | 2.33 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 5.17 | 6.07 | 20.31 |
| 3Y | |||
| 5Y | 9.52 | 31.85 | 28.14 |
| ø p.a.5Y | 1.84 | 5.69 | 5.08 |
Current data
| Net asset value | 23.04.2026 | CHF 1,130.47 |
| High - last 12 months | 25.02.2026 | CHF 1,142.42 |
| Low - last 12 months | 28.04.2025 | CHF 1,053.01 |
| Assets of the unit class in mn | 23.04.2026 | CHF 10.98 |
| Total product assets in mn | 23.04.2026 | CHF 114.08 |
| Theoretical yield to maturity (gross) | 31.03.2026 | 1.52% |
| Modified duration | 31.03.2026 | 2.55 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| UBS MSCI USA Selection UCITS ETF | 9.29 |
| UBS Lux Bond SICAV - USD Investment Grade Corporates USD | 6.11 |
| UBS CH Institutional Fund 4 - Real Estate Switzerland Securities NSL | 5.48 |
| UBS Lux Bond SICAV - EUR Corporates EUR | 4.05 |
| UBS MSCI EM SLECTON-INFDUSQX | 3.00 |
| Roche Holding AG | 2.94 |
| CS Investment Funds 4-Credit Suisse Lux Alternative Opportunities Fund | 2.93 |
| Nestle SA | 2.54 |
| Novartis AG | 2.38 |
| Luzerner Kantonalbank AG | 2.35 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|